Search Results - "Affrime, M. B."

Refine Results
  1. 1

    Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine by Kosoglou, T., Salfi, M., Lim, J. M., Batra, V. K., Cayen, M. N., Affrime, M. B.

    Published in British journal of clinical pharmacology (01-12-2000)
    “…Aims  To evaluate whether ketoconazole or cimetidine alter the pharmacokinetics of loratadine, or its major metabolite, desloratadine (DCL), or alter the…”
    Get full text
    Journal Article
  2. 2

    Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration by Pajkrt, D, Camoglio, L, Tiel-van Buul, MC, de Bruin, K, Cutler, DL, Affrime, MB, Rikken, G, van der Poll, T, ten Cate, JW, van Deventer, SJ

    Published in The Journal of immunology (1950) (15-04-1997)
    “…To determine the effects of IL-10 on cytokine and granulocyte responses during endotoxemia, two groups of eight healthy male volunteers were challenged with…”
    Get full text
    Journal Article
  3. 3

    In vivo effects of interleukin-10 on human cytochrome P450 activity by Gorski, J. Christopher, Hall, Stephen D., Becker, Paula, Affrime, Melton B., Cutler, David L., Haehner‐Daniels, Barbara

    Published in Clinical pharmacology and therapeutics (01-01-2000)
    “…Background Injection of lipopolysaccharide into human volunteers leads to an increase in serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α and a…”
    Get full text
    Journal Article
  4. 4

    Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered-Dose and Dry-Powder Inhalers in Healthy Human Volunteers by Affrime, Melton B., Cuss, Francis, Padhi, Desmond, Wirth, Mark, Pai, Sudhakar, Clement, Robert P., Lim, Josephine, Kantesaria, Bhavna, Alton, Kevin, Cayen, Mitchell N.

    Published in Journal of clinical pharmacology (01-11-2000)
    “…These studies were conducted to assess the systemic bioavailability of mometasone furoate (MF) administered by both the dry‐powder inhaler (DPI) and the…”
    Get full text
    Journal Article
  5. 5

    Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers by Huhn, Richard D., Radwanski, Elaine, Gallo, Jose, Affrime, Melton B., Sabo, Ron, Gonyo, Gerilyn, Monge, April, Cutler, David L.

    Published in Clinical pharmacology and therapeutics (01-08-1997)
    “…Interleukin‐10 inhibits T‐lymphocyte activation and proliferation and lipopolysaccharide‐induced monocyte production of proinflammatory cytokines. Fifty‐four…”
    Get full text
    Journal Article
  6. 6

    Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children by Brannan, Melvin D., Herron, Jerry M., Affrime, Melton B.

    Published in Clinical therapeutics (01-11-1997)
    “…Sensitive and reproducible assessments of hypothalamic-pituitary-adrenal (HPA) axis function were used to assess the systemic exposure and tolerability of…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Pharmacokinetics and Immunomodulatory Properties of Intravenously Administered Recombinant Human Interleukin-10 in Healthy Volunteers by Huhn, Richard D., Radwanski, Elaine, O'Connell, Sean M., Sturgill, Marc G., Clarke, Laura, Cody, Ronald P., Affrime, Melton B., Cutler, David L.

    Published in Blood (15-01-1996)
    “…Normal volunteers received single doses of recombinant human interleukin-10 (rhIL-10; n = 6 per group) or placebo (n = 3 per group) by intravenous injection to…”
    Get full text
    Journal Article
  8. 8

    Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations by Brannan, M D, Reidenberg, P, Radwanski, E, Shneyer, L, Lin, C C, Cayen, M N, Affrime, M B

    Published in Clinical pharmacology and therapeutics (01-09-1995)
    “…To evaluate the effects of coadministration of loratadine and erythromycin on the pharmacokinetics and electrocardiographic repolarization (QTc)…”
    Get more information
    Journal Article
  9. 9

    Population pharmacokinetics of temozolomide in cancer patients by JEN, J. Frank, CUTLER, David L, PAI, Sudhakar M, BATRA, Vijay K, AFFRIME, Melton B, ZAMBAS, Demetris N, HEFT, Samuel, HAJIAN, Gerald

    Published in Pharmaceutical research (01-10-2000)
    “…To evaluate covariate effects on the pharmacokinetics of temozolomide in cancer patients, and to explore the dose-pharmacokinetics-toxicity relationship of…”
    Get full text
    Journal Article
  10. 10

    Single‐dose pharmacokinetics of felbamate in patients with renal dysfunction by Glue, P., Sulowicz, W., Colucci, R., Banfield, C., Pai, S., Lin, C., Affrime, M. B.

    Published in British journal of clinical pharmacology (01-07-1997)
    “…Aims The purpose of this study was to evaluate the effects of renal impairment on the single‐dose pharmacokinetics of the antiepileptic felbamate…”
    Get full text
    Journal Article
  11. 11

    The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years by Salmun, Luis M., Herron, Jerry M., Banfield, Christopher, Padhi, Desmond, Lorber, Richard, Affrime, Melton B.

    Published in Clinical therapeutics (01-05-2000)
    “…Abstract We assessed the pharmacokinetics and tolerability of 5 mg loratadine syrup (1 mg/mL) in children aged 2 to 5 years. Two studies were undertaken. A…”
    Get full text
    Journal Article
  12. 12

    Single and multiple dose pharmacokinetics of felbamate in the elderly by Richens, A., Banfield, C. R., Salfi, M., Nomeir, A., Lin, C. C., Jensen, P., Affrime, M. B., Glue, P.

    Published in British journal of clinical pharmacology (01-08-1997)
    “…Aims The objective of this study was to compare the pharmacokinetics, safety and tolerability of the antiepileptic drug felbamate in young and elderly healthy…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics and leukocyte responses of recombinant human interleukin-10 by RADWANSKI, E, CHAKRABORTY, A, VAN WART, S, HUHN, R. D, CUTLER, D. L, AFFRIME, M. B, JUSKO, W. J

    Published in Pharmaceutical research (01-12-1998)
    “…To study the pharmacokinetics and ex vivo leukocyte responses of recombinant human IL-10 (rHuIL-10) following single s.c. and i.v. dosing. A randomized two-way…”
    Get full text
    Journal Article
  14. 14

    Disposition of Recombinant Human Interleukin-10 in Subjects with Various Degrees of Renal Function by Andersen, Scott R., Lambrecht, Lawrence J., Swan, Suzanne K., Cutler, David L., Radwanski, Elaine, Affrime, Melton B., Garaud, Jean-Jacques

    Published in Journal of clinical pharmacology (01-10-1999)
    “…The pharmacokinetics of intravenously administered recombinant human interleukin‐10 (rHuIL‐10) were evaluated in 18 subjects with creatinine clearances (Clcr)…”
    Get full text
    Journal Article
  15. 15

    Pharmacokinetics of flutamide in patients with renal insufficiency by ANJUM, S, SWAN, S. K, LAMBRECHT, L. J, RADWANSKI, E, CUTLER, D. L, AFFRIME, M. B, HALSTENSON, C. E

    Published in British journal of clinical pharmacology (01-01-1999)
    “…Aims The aim of this study was to determine the pharmacokinetic parameters of flutamide, a nonsteroidal antiandrogenic compound, and its pharmacologically…”
    Get full text
    Journal Article
  16. 16

    Clinical, hematologic, and immunologic effects of interleukin-10 in humans by FUCHS, A. C, GRANOWITZ, E. V, CUTLER, D. L, GRINT, P. C, DINARELLO, C. A, SHAPIRO, L, VANNIER, E, LONNEMANN, G, ANGEL, J. B, KENNEDY, J. S, RABSON, A. R, RADWANSKI, E, AFFRIME, M. B

    Published in Journal of clinical immunology (01-09-1996)
    “…We conducted a double-blind, placebo-controlled study to investigate the safety, pharmacokinetics, and immunological properties of interleukin-10 (IL-10)…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration by Mojaverian, P, Radwanski, E, Affrime, M B, Cayen, M N, Lin, C C

    Published in Antimicrobial Agents and Chemotherapy (01-12-1994)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis by Brannan, Melvin D., Herron, Jerry M., Reidenberg, Pascale, Affrime, Melton B.

    Published in Clinical therapeutics (01-07-1995)
    “…The potential for a newly developed, double-strength (0.084%) beclomethasone dipropionate (BDP) aqueous (AQ) nasal suspension to produce effects associated…”
    Get full text
    Journal Article
  19. 19

    Comparative Pharmacokinetics of Oral Ceftibuten, Cefixime, Cefaclor, and Cefuroxime Axetil in Healthy Volunteers by Nix, David E., Symonds, William T., Hyatt, Judith M., Wilton, John H., Teal, Marilyn A., Reidenberg, Pascale, Affrime, Melton B.

    Published in Pharmacotherapy (01-01-1997)
    “…Study Objective. To compare the pharmacokinetics of ceftibuten, cefixime, cefuroxime axetil, and cefaclor after oral administration. Design. Randomized,…”
    Get full text
    Journal Article
  20. 20

    Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia by PAJKRT, D, VAN DER POLL, T, LEVI, M, CUTLER, D. L, AFFRIME, M. B, VAN DEN ENDE, A, TEN CATE, J. W, VAN DEVENTER, S. J. H

    Published in Blood (15-04-1997)
    “…Interleukin-10 (IL-10) has been found to inhibit lipopolysaccharide (LPS)-induced tissue factor expression by monocytes in vitro. To determine the effects of…”
    Get full text
    Journal Article